VIMO-005

N/A

Report date: 2025/01/26 15:47:18
NME

Base Information

Drug NameVIMO-005
Drug Alias NameAlpha-TEA-based immunotherapy (Veana Therapeutics)Alpha-tocopheryloxyacetic acid-based immunotherapy (Veana Therapeutics)VIMO-005
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionT lymphocytes stimulantsImmunostimulantsApoptosis stimulants
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVeana Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesVeana Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A